| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445921 | European Journal of Cancer | 2012 | 8 Pages |
Abstract
In heavily pre-treated children, VNL combined with CPM showed an interesting response rate in RMS and an acceptable toxicity profile supporting further evaluation of these agents in phase III trials.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Véronique Minard-Colin, Jean-Laurent Ichante, Laurent Nguyen, Angelo Paci, Daniel Orbach, Christophe Bergeron, Anne-Sophie Defachelles, Nicolas André, Nadège Corradini, Claudine Schmitt, Marie-Dominique Tabone, Pascale Blouin, Nicolas Sirvent,